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Background
Low and middle-income countries (LMICs) are facing 
a significant rise in the number of  patients with non-
communicable disease (NCD) risk factors. Rapid scaling up 
of  services is urgently needed, but remain a challenge where 
resources are limited. Effective monitoring and evaluation 
of  developing services is necessary to ensure the quality of  
service offered and clinical effectiveness.
The Malawian health sector has a strong tradition of  
systematic data collection for monitoring and evaluation 
of  large-scale services. A highly successful adapted Directly 
Observed Treatment, Short course, “DOTS” framework, 
based on patient registers and paper-based mastercards was 
introduced to facilitate the management and monitoring of  
the scale up of  antiretroviral therapy (ART)1,2. Within that 
programme a simple, touch-screen based electronic medical 
record system (EMRs) was effectively introduced at high 
burden sites3.
Prior to 2008, diabetes care in Malawi was only available at 
central hospitals and was basic4. A number of  interventions 
(training of  nurse specialists, introduction of  protocols, and 
staff  training) led to a rapid improvement in quality of  care 
in the largest clinic in the country, based at Queen Elizabeth 
Central Hospital in Blantyre. As a model for the scale up 
of  diabetes services nationally, a similar “DOTS” framework 
was introduced to that which had been successfully used for 
the ART scale up. Initially this was a paper-based system 
of  registers and mastercards but with rapid expansion of  
the clinic an electronic medical record system (EMRs) was 
introduced in 20105. This has facilitated consistent medical 
care at an individual level and allowed ongoing monitoring 
and evaluation of  the service.  
The aim of  this study was to use data collected in the 
EMRs to explore clinical and operational outcomes in the 
clinic. The specific aims were to describe the demographic 
characteristics of  patients attending the clinic and examine 
patterns of  glycaemic control from the time of  first 
attendance at the clinic. Operational outcomes included the 
ability to generate quarterly cohort reports and the number 
of  patients undergoing complication screening.
Methods
Study design and setting
We conducted a retrospective, observational study of  both 
newly diagnosed and prevalent patients with a confirmed 
diagnosis of  diabetes mellitus (DM) seen at the Queen 
Elizabeth Central Hospital (QECH) diabetes clinic, 
Blantyre, Malawi between 1/1/2010 and 31/12/2012.  The 
Malawi College of  Medicine Research Ethics Committee 
granted ethical approval for the study (protocol number 
P.03/10/917).
Structure and function of the QECH diabetes clinic
The diabetes clinic at QECH provides free at the point of  
access, tertiary level clinical diabetes services for the 5.8 
million residents of  the Southern region of  Malawi.  The 
clinic also provides primary diabetes care for residents of  
Blantyre living in close proximity to the hospital.  Patients in 
the Southern region of  Malawi received care for DM in their 
local health centres or district hospital and were referred to 
QECH if  they required specialist advice on management or 
complications of  DM.   The clinic is held twice a week, seeing 
50-80 patients at each session with 4-5 clinicians (doctors 
and clinical officers). 
Patients were seen on average 3-4 times per year but this varied 
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depending on clinical need.  Medications were dispensed from 
the central hospital pharmacy at no direct cost to the patient. 
Medications available were basic: glibenclamide was usually 
available in good supply and metformin and insulin in smaller 
quantities so patients were often given only a proportion of  
their prescribed medication. Stock outs of  metformin and 
insulin occurred several times a year and patients were given 
advice about the cheapest pharmacies where these could be 
bought locally. Many patients could not afford to do this. A 
clinic visit involved nurse led group education, measurement 
of  blood pressure, height and weight and blood sampling 
in the morning (after an overnight fast) for fasting blood 
glucose measured using Keylab (Biosed, Italy) or Mindray 
BS120 (Mindray, China) analyser machines in the clinical 
chemistry laboratory at QECH.  Medical reviews typically 
consisted of  an assessment of  glycaemic and blood pressure 
control and overall health. Protocols required that patients 
underwent a foot check at every visit and screening for the 
complications of  DM (nephropathy, retinopathy) at least 
once a year. 
Data entry systems at QECH DM clinic 
On 1/1/2010, a new electronic medical record system 
(EMRs) was introduced at the clinic in partnership with 
Baobab Health Trust (BHT) to replace the paper-based 
system. Clinicians working in the diabetes clinic who worked 
with BHT to design the system suggested the EMR fields. 
Briefly, a touch screen clinical workstation was used at the 
point of  care by clinic staff  to manually enter data in real time 
during each clinic visit.  Non-variable data, for example, date 
of  birth, physical address, gender and date of  diagnosis were 
recorded by nurses or clerical staff  at first registration for new 
patients.  For prevalent patients, the data were transcribed 
from historical paper records just before the EMRs went 
live. The EMRs’ clinical workstations were connected to a 
central server located at QECH using a local area network. 
All the registered patients’ data was stored in a database 
on the local server. Data for this study was extracted from 
the database into a Microsoft Excel spreadsheet by BHT’s 
system developers. A query was run on the extracted data to 
anonymise all the patients’ data before the data was shared 
for analysis. Identification of  the anonymised patients was 
through system-generated unique patient IDs and unique 
clinic reference number.
Data analysis
Data was extracted from the Diabetes Clinic EMRs to 
obtain a patient level dataset of  all clinic visit dates and the 
accompanying clinical data recorded on the visit. Multiple 
visits were thus recorded per patient. Each visit included a 
measure of  blood glucose level and body-mass index (BMI). 
For analysis of  glycaemic control we calculated weeks since 
first visit by subtracting date of  the patient’s registration at the 
clinic from visit date and dividing by 7. Records with missing 
values for blood glucose or body mass index at baseline 
were dropped from analysis; the EMR database enforced the 
entry of  values for the date of  the patient’s registration at 
the clinic, date of  birth, and baseline HIV status. Patients 
who had registered at the clinic prior to the introduction 
of  the EMR were classified as ‘previously diagnosed’, while 
patients who registered at the clinic after the introduction of  
the EMR were classified as ‘newly diagnosed’. 
To explore whether demographic or clinical factors affected 
the course of  glycaemic control we examined the trajectories 
of  blood glucose levels from time since registration within 
patient groups. To do this, we calculated the 25th, 50th 
(median) and 75th percentile of  blood glucose level within 
the patient group within 4 week groupings of  time since 
registration. For each percentile group (25th, 50th and 75th) 
we plotted the trajectory of  blood glucose values over time. 
Patient groups examined were those newly diagnosed with 
diabetes (incident cases) vs those registered with extant 
diabetes (prevalent cases); among incident cases we looked 
at subgroup analysis of  those with a baseline BMI> 25, 18-
25 and <18, respectively and patients with a baseline age <45 
years versus ≥ 45 years. Descriptive statistics were generated 
directly from the excel sheets using Microsoft Excel.  
Results
Prevalent and incident cases
During the 3 years of  study, 2,470 patients were registered 
in the EMRs.  Of  these 1,112 were prevalent cases, that is 
known diabetics at the time of  registration on the EMRs and 
636 were incident cases diagnosed during the 3 years of  data 
collection; 186 in 2010, 249 in 2011 and 201 in 2012. Data on 
year of  diagnosis was not recorded for 722 subjects.
Demographic and clinical data at registration
1466 (59%) subjects were female and 1004 (41%) were 
male. The median age of  patients was 53 years, interquartile 
range 42-62years. Twenty-four were aged <16 years. The 
median duration of  diabetes for prevalent cases was 5 years, 
interquartile range 2-10 years. Clinical data at registration was 
incomplete; for example family history was only documented 
for 794 (32%) cases (427 positive), TB history for 1688 
(68%, 20 positive) and smoking history for 370 (7 current 
smokers). Data for remaining baseline clinical parameters 
were too incomplete to present.
HIV status at the time of registration
Data on HIV status was not documented for 1,132 (46%) 
subjects. Of  the remainder, 618 subjects had an unknown 
status, 540 had a recent non-reactive status and 180 (13.5% 
of  those for whom information was recorded) were HIV 
reactive. Of  these 154 (85.6%) were taking antiretroviral 
therapy (ART). 
Glycaemic control
Serial glucose readings, since diagnosis, for incident cases is 
shown in Figure 1 (upper panel). Serial glucose measurements 
for prevalent cases since first recording on the EMRs is shown 
in figure 1 (lower panel). Newly diagnosed cases seemed to 
make steady progression to glucose control from 0 to 26 
weeks and generally maintained <150 mg/dL thereafter, 
whereas previously diagnosed subjects had overall worse 
control, taking longer to get to <150mg/dL (52 weeks), with 
some deterioration in control after 104 weeks.
Information on diabetes type (Type 1 or type 2), although 
required to be entered on the EMRs at the first visit, was 
largely unrecorded so subgroup analysis of  newly diagnosed 
(incident) cases was carried out based on age and BMI. Serial 
glucose measurements were analysed separately in those 
aged ≥45 years at time of  diagnosis (Figure 2 upper panel) 
and those aged <45 (Figure 2 lower panel) and those with 
BMI >25 (Figure 3 upper panel) and those with BMI 18-25 
(Figure 3 lower panel). Figure 2 illustrates that those aged 
<45 years start with higher blood glucose measurements but 
attain control by about 14 weeks. 
http://dx.doi.org/10.4314/mmj.v29i4.8
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the 18-25 BMI group 
may account for the 
fluctuations in glucose 
levels seen later on. Data 
for those with BMI <18 
is not presented as the 
numbers were small.
Complication data
The EMRs included 
fields where the 
complications of  
diabetes (retinopathy, 




could be recorded in 
a systematic way. The 
EMRs dashboard 
included prompts, so 
that a complication 
screen that had not 
been entered within 
the previous year 
was highlighted. 
Despite this data on 
the complications 
of  DM was poorly 
recorded. Less than 
10% of  subjects had any 




As well as a tool 
to facilitate clinical 
management one 
of  the main reasons 
for introducing the 
EMRs was to facilitate 
monitoring and 
evaluation, particularly 
through the production 
of  quarterly cohort 
reports. This included 
data on new and 
cumulative registrations, 
outcomes (alive and 
on treatment, dead, 
transferred out, default 
and stop treatment), 
medication usage and 
complications. These 
reports were produced quarterly and forwarded to the 
Ministry of  Health. Although registration data was more 
or less accurate, and useful, the other parameters were of  
questionable value due to missing data.
Discussion
This analysis of  an EMRs with data recorded on over 2000 
diabetic patients over 3 years provides some fascinating 
insights into the operational challenges of  implementing 
an EMRs for a complex condition and the effectiveness of  
Thereafter, from week 38 onwards glycaemic control was 
more variable. This group may contain a higher proportion 
of  type 1 diabetics. Subjects aged ≥45 years take longer to 
gain control (26 weeks), but thereafter have more consistent 
glycaemic levels than those aged <45 years. Figure 3 
illustrates that those who are of  normal BMI present with 
higher blood glucose readings and attain control by 30 weeks 
whereas the overweight (BMI >25) have lower initial glucose 
values, achieve glucose control by 26 weeks and maintain it 
over time. Again, the group with a normal BMI may include 
a higher proportion of  type 1 diabetics. Small numbers in 
Figure 1: Serial glucose measurements for incident and prevalent cases
Figure 2 Serial glucose measurements stratified by age 45 years
http://dx.doi.org/10.4314/mmj.v29i4.8
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diabetes care, in terms of  glycaemic control, in a resource 
poor setting.
Operational challenges
Unlike the ART EMRs used for HIV care, on which the 
diabetes EMRs was based, where all fields are compulsory, 
the diabetes EMRs included only a few compulsory fields 
and a large number of  optional fields. It has become 
apparent that this allows for a large amount of  missing 
data. Furthermore, the ART EMRs is directly linked to care: 
thus a patient can only obtain ART through an electronic 
prescription and dispensing generated by the EMRs in the 
site where they are registered. Conversely diabetic patients 
can collect medication, with or without an electronic 
prescription, from many providers, both government and 
private.  Thus the requirement to complete the EMRs does 
not link directly to outcomes. The diabetes EMRs has the 
functionality to print out summary stickers and prescriptions 
that can be stuck in the health passport (a patient kept health 
record that records basic information on the consultation 
and is used for prescribing medication. All patients in Malawi 
have these and bring them when attending clinics). When 
used frequently the stickers speed up consultation time and 
increase accuracy of  prescribing. However, with a high turn 
over of  clinicians who are unfamiliar with the EMRs the 
advantages are not recognised. The diabetes EMRs was also 
undoubtedly complex which was a deterrent to some users. 
In addition, there were often more clinicians in clinic than 
touch screen workstations available so some missing data 
was inevitable. Systematic recording of  complications is a 
challenge in all diabetic clinics and in high volume clinics, with 
large numbers of  patients and few clinicians; complications 
are not systematically screened for. This is compounded 
by shortages of  consumable materials such as dipstick for 
urine protein and reagents for creatinine measurement to 
screen for nephropathy. The design of  the diabetes EMRs, 
with prompts when complication screening was needed, 
did not have the desired effect. In this analysis we are only 
evaluating use of  the EMRs and cannot comment on the 
actual clinic practices of  
complication screening. 
We know that 
complication rates 
are high4,6 and robust 
processes need to be 
implemented to ensure 
that these patients are 
identified. However, 
registration data was 
generally well recorded 
and that aspect of  the 
EMRs was one of  its 
strengths. 
Glycaemic control
The serial data on 
glycaemic control 
is unique and 
demonstrates the 
potential that EMRs can 
have for understanding 
clinical processes and 
clinical trajectories in 
patients. It is reassuring 
to note that most newly 
presenting diabetics (incident cases) achieve and maintain 
glycaemic control (Figure 1). The time taken (26 weeks) for 
acceptable control (Fasting blood glucose (FBG) less than 
150mg/dL) to be reached reflects our clinic protocols, with an 
emphasis on life style changes initially for the first 3 months, 
in those with FBG <300 mg/dL then gradual introduction 
of  oral hypoglycaemic agents (OHAs) for those that are still 
above target.  It is interesting to consider why prevalent cases 
seem to have worse glycaemic control. This may be a result 
of  new patients taking on board the health messages more 
than our long-term patients. The education programme 
was stronger during the period of  observation compared to 
before 2010. Equally, this finding may relate to the duration 
of  DM. We know from the pathophysiology of  type 2 DM 
that glycaemic control deteriorates over time, requiring up 
titration of  OHAs and eventually a switch to insulin. Perhaps 
many of  the prevalent cases needed more aggressive medical 
management. The observation that overall their control 
did improve over the first year of  the EMRs suggests that 
the training of  clinicians and introduction of  treatment 
protocols in 2009 may have been having some impact. The 
deterioration in control in some subjects later on may also 
reflect challenges with obtaining medication since stock outs, 
particularly of  metformin and insulin were more common 
in 2012.
The subgroup analyses by BMI also suggest that, in a 
situation where drug supplies may be constrained, lifestyle 
interventions have an important role to play. One of  the 
mainstays of  glycaemic control at the QECH clinic is lifestyle 
change, especially dietary modification and weight loss. The 
data suggests that it is easier to treat overweight diabetics 
because they will benefit most from non-pharmacological 
intervention. Conversely, the normal BMI patients start with 
higher fasting blood glucose levels and are, therefore, more 
likely to start on medication from their first visit, hence their 
glycaemic control improves more quickly. However, their 
subsequent control is more variable because they have less 
to gain by lifestyle change so treatment interruptions will 
Figure 3: Serial glucose measurements stratified by BMI 18-25 and >25
http://dx.doi.org/10.4314/mmj.v29i4.8
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have more impact. This group may include more varied 
phenotypes including type 1DM. The analysis by age reflects 
a similar picture. 
The Ministry of  Health are working with BHT to design 
and pilot new EMRs for non-communicable diseases namely 
hypertension, asthma, epilepsy, and diabetes. Based on our 
experience of  the EMRs at QECH these new systems need 
to be simplified, have mainly compulsory data fields and 
ideally be more closely aligned to care, through registration 
and prescription. Clinicians who are using the EMRs need 
ongoing training and supervision. Continuous review of  the 
data from the EMRs will help to identify where the gaps are 
coming from and can assist in identifying and working on 
areas where Quality Improvement Projects, within the clinic, 
will improve data capture.
Conclusion
In conclusion, our analysis of  the first 3 years of  data 
collected in the EMRs at Queen Elizabeth Hospital illustrates 
both the strengths and weaknesses of  the electronic system. 
The potential for electronic records to facilitate clinical 
care, monitoring and evaluation are evident and, with 
better design and access to work stations for all clinicians 
similar EMRs could be useful for all chronic diseases. It is 
also apparent that clinicians using electronic systems need 
ongoing training, mentorship and supervision. If  based 
on a common platform integration of  electronic records 
for NCDs and HIV from different sites would provide a 
powerful database with the potential to provide a unique 
understanding of  epidemiology, efficient service planning 
and improved care.
Clinical lessons from the analysis of  glycaemic control 
suggest that different patient groups may require a different 
approach to management, particularly younger patients and 
those with lower BMIs who have more variable glycaemic 
control. This may require modification of  protocols and 
alternative education messages including more intensive 
support to medication adherence for these groups. In those 
with long term diabetes protocols already reflect the need to 
escalate treatment as control deteriorates. These protocols 
need to be more closely applied and patients may benefit 
from modified education messages to maintain control with 
longer duration of  diabetes.
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